Primary |
Infarction |
66.7% |
Stent Placement |
33.3% |
|
|
Secondary |
Atrial Fibrillation |
16.7% |
Cardiac Failure |
16.7% |
Hypertension |
16.7% |
Oedema Peripheral |
11.1% |
Product Used For Unknown Indication |
11.1% |
Benign Prostatic Hyperplasia |
5.6% |
Cardiovascular Disorder |
5.6% |
Cerebrovascular Accident Prophylaxis |
5.6% |
Sleep Disorder |
5.6% |
Hypercholesterolaemia |
2.8% |
Sinusitis |
2.8% |
|
Premature Separation Of Placenta |
25.0% |
Sudden Death |
25.0% |
Hyperglycaemia |
12.5% |
Malaise |
12.5% |
Muscle Haemorrhage |
12.5% |
Pre-existing Condition Improved |
12.5% |
|
Concomitant |
Drug Use For Unknown Indication |
21.1% |
Product Used For Unknown Indication |
18.1% |
Hypertension |
13.1% |
Multiple Myeloma |
7.7% |
Prophylaxis |
7.5% |
Plasma Cell Myeloma |
4.3% |
Cardiomyopathy |
3.8% |
Thrombosis Prophylaxis |
3.4% |
Rheumatoid Arthritis |
2.2% |
Atrial Fibrillation |
2.1% |
Depression |
2.1% |
Insomnia |
2.1% |
Constipation |
1.9% |
Type 2 Diabetes Mellitus |
1.9% |
Bone Pain |
1.6% |
Non-small Cell Lung Cancer |
1.6% |
Diabetes Mellitus |
1.4% |
Hypercholesterolaemia |
1.4% |
Renal Transplant |
1.4% |
Herpes Virus Infection |
1.3% |
|
Death |
12.5% |
Cardiac Failure |
11.1% |
Vomiting |
11.1% |
Adenocarcinoma Pancreas |
8.3% |
Tenosynovitis |
5.6% |
Bronchospasm |
4.2% |
Diarrhoea |
4.2% |
Osteonecrosis |
4.2% |
Pneumonia |
4.2% |
Renal Failure Acute |
4.2% |
Septic Shock |
4.2% |
Weight Decreased |
4.2% |
Acute Myocardial Infarction |
2.8% |
Anxiety |
2.8% |
Blood Creatinine Increased |
2.8% |
Chest Pain |
2.8% |
Confusional State |
2.8% |
Dehydration |
2.8% |
Dysphemia |
2.8% |
Fracture Nonunion |
2.8% |
|
Interacting |
Infarction |
40.0% |
Stent Placement |
20.0% |
Atrial Fibrillation |
10.0% |
Cerebrovascular Accident Prophylaxis |
10.0% |
Hypercholesterolaemia |
10.0% |
Sinusitis |
10.0% |
|
Lymphoma |
50.0% |
Muscle Haemorrhage |
50.0% |
|